Literature DB >> 4593708

Urinary fibrinogen derivative excretion and intraglomerular fibrin deposition in glomerulonephritis.

P Naish, D J Evans, D K Peters.   

Abstract

The relations between glomerular fibrin deposition, urinary excretion of fibrinogen derivatives (F.D.), and proteinuria were explored in 81 patients with glomerulonephritis. A positive correlation existed between proteinuria and F.D. excretion even when no fibrin could be detected in the glomerulus. In two patients with tubular proteinuria F.D. excretion was also raised, suggesting that tubular reabsorption or catabolism of F.D. or both normally occur.Disproportionately high titres of F.D. were observed when fibrin was deposited in an extracapillary site, but mesangial fibrin deposition was not accompanied by a higher excretion of F.D. than that observed in patients in whom intraglomerular fibrin was not detected. These observations suggest that the immunofluorescent findings on renal biopsies should be the major criteria on which a trial of anticoagulants in proliferative glomerulonephritis might be instituted and that measurement of urinary F.D. is likely to be of value in monitoring therapy in patients with extracapillary fibrin deposition.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4593708      PMCID: PMC1633662          DOI: 10.1136/bmj.1.5907.544

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  THE PATHOGENIC ROLE OF THE COAGULATION PROCESS IN RABBIT MASUGI NEPHRITIS.

Authors:  P VASSALLI; R T MCCLUSKEY
Journal:  Am J Pathol       Date:  1964-10       Impact factor: 4.307

2.  PROTECTIVE ACTION OF HEPARIN IN EXPERIMENTAL IMMUNE NEPHRITIS.

Authors:  B HALPERN; P MILLIEZ; G LAGRUE; A FRAY; J C MORARD
Journal:  Nature       Date:  1965-01-16       Impact factor: 49.962

3.  Effects of heparin on experimental nephritis in rabbits.

Authors:  J KLEINERMAN
Journal:  Lab Invest       Date:  1954 Nov-Dec       Impact factor: 5.662

4.  Identification of intrarenal fibrin deposition.

Authors:  A M Davison; D Thomson; M K Macdonald; J K Rae; W S Uttley; A R Clarkson
Journal:  J Clin Pathol       Date:  1973-02       Impact factor: 3.411

5.  Glomerular abnormalities in nonsystemic diseases. Relationship between findings by light microscopy and immunofluorescence in 433 renal biopsy specimens.

Authors:  L Morel-Maroger; A Leathem; G Richet
Journal:  Am J Med       Date:  1972-08       Impact factor: 4.965

6.  The effect of defibrination on nephrotoxic serum nephritis in rabbits.

Authors:  P Naish; G B Penn; D J Evans; D K Peters
Journal:  Clin Sci       Date:  1972-05       Impact factor: 6.124

7.  Cortical fibrinolytic activity in normal and diseased human kidneys.

Authors:  J M Bergstein; A F Michael
Journal:  J Lab Clin Med       Date:  1972-05

8.  Increased urinary fibrinogen derivatives after renal allotransplantation.

Authors:  P Naish; D K Peters; R Shackman
Journal:  Lancet       Date:  1973-06-09       Impact factor: 79.321

9.  A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum.

Authors:  C Merskey; P Lalezari; A J Johnson
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

10.  Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.

Authors:  A R Clarkson; M K MacDonald; J J Petrie; J D Cash; J S Robson
Journal:  Br Med J       Date:  1971-08
  10 in total
  9 in total

1.  Fibrinogen excretion in the urine and immunoreactivity in the kidney serves as a translational biomarker for acute kidney injury.

Authors:  Dana Hoffmann; Vanesa Bijol; Aparna Krishnamoorthy; Victoria R Gonzalez; Gyorgy Frendl; Qin Zhang; Peter L Goering; Ronald P Brown; Sushrut S Waikar; Vishal S Vaidya
Journal:  Am J Pathol       Date:  2012-07-20       Impact factor: 4.307

Review 2.  An evaluation of experimental models of glomerulonephritis.

Authors:  P N Furness; K Harris
Journal:  Int J Exp Pathol       Date:  1994-02       Impact factor: 1.925

3.  Clinical detection of rejection nephropathy using 125I-labelled fibrinogen.

Authors:  P Niederle; I Reneltová; P Rossmann; J Jirka; I Prerovský
Journal:  Int Urol Nephrol       Date:  1976       Impact factor: 2.370

4.  Coagulation and fibrinolytic activity of cerebrospinal fluid.

Authors:  M Anderson; K B Matthews; J Stuart
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

5.  [Fibrin degradation products in the urine and glomerulopathies in children].

Authors:  M G Song; Y Q Wang; X M Xu
Journal:  Acta Acad Med Wuhan       Date:  1982

6.  Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury.

Authors:  Aparna Krishnamoorthy; Amrendra Kumar Ajay; Dana Hoffmann; Tae-Min Kim; Victoria Ramirez; Gabriela Campanholle; Norma A Bobadilla; Sushrut S Waikar; Vishal S Vaidya
Journal:  Blood       Date:  2011-06-17       Impact factor: 22.113

7.  Urinary fibrin-fibrinogen degradation products in nephrotic syndrome.

Authors:  C L Hall; N Pejhan; J M Terry; J D Blainey
Journal:  Br Med J       Date:  1975-02-22

8.  Fibrin deposits in the glomeruli and fibrin/fibrinogen degradation products (FDP) in the blood and urine in some renal diseases.

Authors:  I Tishkov; C Tschoukanov; D Doytshinov; P Shipkova
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

9.  Urinary excretion of C3 antigen in glomerulonephritis.

Authors:  B D Williams; A R Clarkson; P G Row; R J Groves; J S Cameron
Journal:  Br Med J       Date:  1974-10-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.